DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Small Molecule Drugs cited in Dexcel Pharma Technologies Ltd. v. Apotex Corp.
|Date Filed||Document No.||Description||Snippet||Link To Document|
|2018-07-30||3||memorandum in support of motion||infringed two Dexcel-owned patents, i.e., U.S. Patents 9,023,391 (“the ’391 Patent,” granted May 5, 2015) … the patents-in-issue during the time she worked as a patent agent, and prosecuted these patents for Dexcel…relating to the patents-in-suit, as Dexcel’s U.S. patent agent, fall squarely within this patent-agent privilege…,255,878 (“the ’878 Patent,” granted August l4, 2007), collectively, the “patents-in-suit”. The action…Graeser”) is a U.S. patent agent, and has been registered to practice before the U.S. Patent and Trademark||External link to document|
|>Date Filed||>Document No.||>Description||>Snippet||>Link To Document|